Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed <i>NPM1</i> -Mutated or <i>KMT2A</i> -Rearranged AML
Joshua F. Zeidner(University of North Carolina at Chapel Hill), Alice S. Mims(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Elie Traer(Memorial Sloan Kettering Cancer Center), Wendy Stock(University of Chicago), Kristin L Koenig(The Ohio State University), Uma Borate(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Vu H. Duong(University of Maryland, Baltimore), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Ying Huang(The Ohio State University), Sonja Marcus(Leukemia and Lymphoma Society), Ronan Swords(University of Miami), Brian Druker(Oregon Health & Science University), Mona Stefanos(The Ohio State University), Tara L. Lin(Dana-Farber Cancer Institute), Angela D. Nichols(University of North Carolina at Chapel Hill), Gary J. Schiller(Fred Hutch Cancer Center), Molly Martycz(The Ohio State University), Maria R. Baer(University of Maryland, Baltimore), Timothy L. Chen(The Ohio State University), Olatoyosi Odenike(University of Chicago), Ashley O. Yocum(Leukemia and Lymphoma Society), Eytan M. Stein(Memorial Sloan Kettering Cancer Center), Rebecca L. Olin(University of California, San Francisco), Len Rosenberg(Leukemia and Lymphoma Society), Michael J. Hochman(Emory University), Sheng F. Cai(Memorial Sloan Kettering Cancer Center), Curtis A. Lachowiez(Oregon Health & Science University), Emily Curran(University of Cincinnati), Yazan F. Madanat(The University of Texas Southwestern Medical Center), Catherine C. Smith(University of California, San Francisco), John C. Byrd(University of Cincinnati), Rina Li Welkie(The Ohio State University), William Blum(The Ohio State University)
Cited by 36
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k